Abstract
Rationale: Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Increasing evidence has implicated physiological impairments in the increased risk of malnutrition. Emerging evidence supports the use of dietary supplements to counteract common deficiencies seen in MS patients, such as Vitamin D, B12, Omega 3 and CoenzymeQ10(Q10). The aim of this study was to gain insights into behaviours relating to dietary modifications, supplement use and quality of life (QOL) impact in patients with Relapsing-Remitting MS (RRMS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
